SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,249.13 -82.20
(-0.17%)

Dow Jones

7,185.72 56.32
(0.79%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Mankind Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543904

INE634S01028

375.7133845

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MANKIND

52.96

93581.99

EPS(TTM)

Face Value()

Div & Yield %

42.8

Back

Anlon Healthcare reports standalone net profit of Rs 5.15 crore in the December 2025 quarter

Feb 09,2026

Net profit of Anlon Healthcare reported to Rs 5.15 crore in the quarter ended December 2025 as against net loss of Rs 2.49 crore during the previous quarter ended December 2024. Sales rose 280.13% to Rs 35.58 crore in the quarter ended December 2025 as against Rs 9.36 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	35.58	9.36	280
OPM %	34.68	6.20	-
PBDT	10.96	-0.29	LP
PBT	10.61	-0.29	LP
NP	5.15	-2.49	LP

76,664.21 -999.79 ( -1.29%)

49,249.13 -82.20 (-0.17%)

7,185.72 56.32 (0.79%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)